Clinical Trials

Showing trials with last updates posted in 2025.

NCT03635892 | ACTIVE_NOT_RECRUITING | PHASE2
60 participants

A Study of Nivolumab In Combination With Cabozantinib in Patients With Non-Clear Cell Renal Cell Carcinoma

Study Type:
INTERVENTIONAL
Last Updated:
2025-09-22
Start Date:
2018-08-13
Completion:
2026-08-31
Conditions
  • Advanced or Metastatic Non-clear Cell Renal Cell Carcinoma
  • Unclassified Renal Cell Carcinoma
  • Papillary Renal Cell Carcinoma
  • Fumarate Hydratase Deficient Renal Cell Carcinoma
  • Succinate Dehydrogenase Deficient Renal Cell Carcinoma
  • Collecting Duct Renal Cell Carcinoma
  • Chromophobe Renal Cell Carcinoma
Interventions
  • DRUG
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page